Results 151 to 160 of about 37,718 (165)

Highly genetically diverse variants of hepatitis C virus still predominate in Cameroon but with low frequency of mutations associated to resistance of NS5B polymerase-targeted antivirals. [PDF]

JAC Antimicrob Resist
Levoa Eteme F, Mafopa Goumkwa N, Otam AL, Lobe C, Yengo CK, Kowo M, Tchapda L, Pempeme I, Ngameleu WA, Engarimbi JE, Ndonku SA, Yannick DN, Awoumou PL, Kwizera MA, Oudou N, Okomo MCA, Fokunang CN, Luma HN, Torimiro JNE.   +18 more
europepmc   +1 more source

Strengthening research capacity in Cameroon: qualitative insights on the impact of mentorship, training and funding on receiving seed grants. [PDF]

BMJ Public Health
Buser JM, Fouogue J, August E, Gray RL, Hailu D, Endale T, Smith YR, Fouedjio J.   +7 more
europepmc   +1 more source

Trends and determinants of unfavourable outcomes in paediatric tuberculosis: insights from a 20-year cohort in Cameroon. [PDF]

BMJ Open Respir Res
Poka-Mayap V, Dombu-Guiafaing RC, Balkissou AD, Endale Mangamba LM, Kuaban A, Nsounfon AW, Massongo M, Ngah Komo ME, Ntyo'o Nkoumou AL, Pefura-Yone EW.   +9 more
europepmc   +1 more source

Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. [PDF]

Nat Commun
Noubiap JJ, Nansseu JR, Nyaga UF, Ndoadoumgue AL, Ngouo AT, Tounouga DN, Tianyi FL, Foka AJ, Lontchi-Yimagou E, Nkeck JR, Bigna JJ.   +10 more
europepmc   +1 more source

Prevalence of antimalarial drug resistance molecular markers in Makenene, central Cameroon. [PDF]

Int J Parasitol Drugs Drug Resist
Kala-Chouakeu NA, Djoufounna J, Benoit N, Tchuinkam T, Delandre O, Almeras L, Bamou R, Antonio-Nkondjio C, Madamet M, Pradines B.   +9 more
europepmc   +1 more source

Association of knockdown resistance mutations with pyrethroid resistance in Aedes aegypti, a major arbovirus vector in Cameroon. [PDF]

Parasit Vectors
Keumeni CR, Yougang AP, Njiokou F, Clarke SE, Lines J, Wondji C, Kamgang B.   +6 more
europepmc   +1 more source

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options. [PDF]

AIDS Res Ther
Fokam J, Anim-Keng TT, Pokam BT, Chenwi CA, Ka'e AC, Semengue ENJ, Beloumou Angong OEG, Takou D, Nka AD, Djupsa S, Etame NK, Molimbou E, Ajeh R, Bissek AZ, Colizzi V, Perno CF, Halle-Ekane GE, Ndembi N, Ndjolo A.   +18 more
europepmc   +1 more source

Assessing hepatitis C self-testing within differentiated care models in Cameroon: Feasibility, acceptability, and linkage to care for key and priority populations. [PDF]

PLOS Glob Public Health
Mboussam HP, Kouenkap SBS, Tchikangni G, Tchamy I, Mabally AM, Saamene JA, Ndié J, Adah RA, Mballa GAE, Abah AA, Mbella M, Bissek AZ, Billong SC, Kerschberger B, Dunkley Y, Kowo M, Johnson CC, Bajis S, Hatzold K.   +18 more
europepmc   +1 more source